Jonathan Webster

Also affiliated with Sidney Kimmel Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia”.

CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia

Cancer Research(2021)10.1158/0008-5472.can-20-1504

N/A

0.345DataRank · unranked

9 citations

Nicole D. Vincelette, Cordelia D. McGehee, Mira A. Kohorst, Brian D. Koh, Annapoorna Venkatachalam +16 more

A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML

Leukemia Research(2021)10.1016/j.leukres.2021.106737

N/A

0.330DataRank · unranked

8 citations

Tara M. Robinson, Amanda L. Blackford, Erica D. Warlick, Anna Ferguson, Ivan Borrello +4 more

A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG‐ACRIN EA9152 protocol

eJHaem(2024)10.1002/jha2.991

N/A

0.297DataRank · unranked

5 citations

Ju‐Whei Lee, David F. Claxton, Elisabeth Paietta, Hassan B. Alkhateeb, Jae H. Park +8 more

Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.02.004

N/A

0DataRank · unranked

27 citations

Hua‐Ling Tsai, Amy E. DeZern, Lukasz P. Gondek, Hany Elmariah, Javier Bolaños‐Meade +22 more

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.12.018

N/A

0DataRank · unranked

7 citations

Madison Reed, Hua‐Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern +25 more

Data from CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia

(2023)10.1158/0008-5472.c.6512716.v1

N/A

0DataRank · unranked

0 citations

Nicole D. Vincelette, Cordelia D. McGehee, Mira A. Kohorst, Brian D. Koh, Annapoorna Venkatachalam +16 more

Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Blood Advances(2020)10.1182/bloodadvances.2020002945

N/A

0DataRank · unranked

31 citations

Leo Luznik, Hua-Ling Tsai, Philip Imus, Amy E. DeZern, Keith W. Pratz +21 more

Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities

Leukemia Research(2025)10.1016/j.leukres.2025.108098

N/A

0DataRank · unranked

1 citations

Daniel Li, Hua‐Ling Tsai, Gabriel Ghiaur, B. Douglas Smith, Mark J. Levis +10 more

Treatment of AML Relapse After Allo-HCT

Frontiers in Oncology(2021)10.3389/fonc.2021.812207

N/A

0DataRank · unranked

36 citations

Leo Luznik, Ivana Gojo, Jonathan Webster

Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.09.022

N/A

0DataRank · unranked

6 citations

Matthew L. Smith, Hua‐Ling Tsai, Ravi Varadhan, Amy E. DeZern, W. Brian Dalton +23 more